home / stock / cntg / cntg news


CNTG News and Press, Centogene N.V. From 10/19/20

Stock Information

Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NASDAQ
Website: centogene.com

Menu

CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...

CNTG - CS, AMC among premarket gainers

Kaixin Auto Holdings (KXIN) +57%.Midatech Pharma plc (MTP) +42% after announcing positive results from a Phase I study evaluating MTX110.Front Yard Residential (RESI) +34% after announcing going private deal valued at ~$2.4B.ARC Document Solutions (ARC) +26% on prelim...

CNTG - FDA OKs emergency use of Centogene coronavirus test for asymptomatic people

The FDA has signed off on emergency use of Centogene's (CNTG) Centosure SARS-CoV-2 RT-PCR molecular test for asymptomatic individuals, clearing the way for its use in widespread testing during the pandemic.Shares up 15% premarket. For further details see: FDA OKs emergency use...

CNTG - CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay for Individuals Without Symptoms or Other Reasons to Suspect COVID-19

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutica...

CNTG - Centogene and U-Diagnostics joined forces to increase COVID-19 testing capacities

Centogene (CNTG) +2.9% PM, and U-Diagnostics collaborated to provide increased COVID-19 testing to communities across Netherlands as the country faces a shortage of testing capacities amid rising infections.Under the agreement, CENTOGENE will assist in providing CentoSwab, its CE-la...

CNTG - Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Netherlands

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and BAARN, the Netherlands, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patient...

CNTG - FDA OKs emergency use of Centogen molecular coronavirus test

The FDA grants emergency use authorization to Centogene's ([[CNTG]] +0.5%) SARS-CoV-2 RT PCR (real-time polymerase chain reaction) assay that qualitatively (yes/no answer) detects genetic material from the coronavirus in oropharyngeal swab specimens.Testing is limited to CLIA-certified labs. ...

CNTG - CENTOGENE's Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation

Company awarded ISO 27001 Accreditation for its Information Security Management System The internationally recognized certification is set by the International Organization for Standardization (ISO), in partnership with the International Electrotechnical Commission (IEC) Accredita...

CNTG - Centogene N.V. (CNTG) CEO Arndt Rolfs on Q2 2020 Results - Earnings Call Transcript

Centogene N.V. (CNTG) Q2 2020 Results Conference Call September 23, 2020 8:00 AM ET Company Participants Sun Kim - Investor Relations Arndt Rolfs - Chief Executive Officer Richard Stoffelen - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Sung Ji Nam - BTIG Ca...

CNTG - Centogene N.V. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Centogene N.V. in conjunction with their 2020 Q2 earnings call. For further details see: Centogene N.V. 2020 Q2 - Results - Earnings Call Presentation

CNTG - Centogene reports Q2 results

Centogene (CNTG): Q2 GAAP EPS of -€0.52.Revenue of €9.7M (-13.5% Y/Y)Shares +1% PM.Press Release For further details see: Centogene reports Q2 results

Previous 10 Next 10